A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
Schwartzberg LS, Yee LK, Senecal FM, et al.
Oncologist 2004;9(6):696-707.
Review by
Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: Results of a randomized, controlled trial.
Iconomou G, Koutras A, Rigopoulos A, Vagenakis AG, Kalofonos HP
J Pain Symptom Manage 2003;25(6):512-518.
Review by
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.
Hedenus M, Adriansson M, Miguel JS, et al.
Br J Haematol 2003;122(3):394-403.
Review by
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
Cazzola M, Beguin Y, Kloczko J, Spicka I, Coiffier B
Br J Haematol 2003;122(3):386-393.
Review by
The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH
Laryngoscope 2002;112(7):1221-1229.
Review by Henry DH
Transfusion in premature infants impairs production and/or release of red blood cells, white blood cells and platelets.
The author concludes that suppression of erythro-, leuko- and thrombopoiesis within 48 hours after transfusion decreases the amount of precursor cells in the peripheral blood.... Read More
The theory and practice of bloodless surgery.
A very thorough overview of all aspects of blood-sparing methods. – V. Kretschmer
Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.
The authors evaluated a low dose iron substitution scheme for the effectiveness in patients with peritoneal dialysis: 50 mg iron sucrose every other week is... Read More
Iron administration and clinical outcomes in hemodialysis patients.
Feldman HI, Santanna J, Guo WS, et al.
J Am Soc Nephrol 2002;13(3):734-744.
Review by Gasche C
The effect of i.v. iron alone or in combination with low- dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS, Blum M, Agbaria Z, et al.
Clin Nephrol 2001;55(3):212-219.
Considerations for optimal iron use for anemia due to chronic kidney disease.
Hudson JQ, Comstock TJ
Clin Ther 2001;23(10):1637-1671.
Outcome of infants receiving in-utero transfusions for haemolytic disease.
Farrant B, Battin M, Roberts A
N Z Med J 2001;114(1139):400-403.
Review by